Spring House, PA, United States of America

Jarrat Jordan

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Janssen Biotech, Inc., Centocor Ortho Biotech Inc.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jarrat Jordan. Retrieved from https://idiyas.com/inventor/jarrat-jordan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Radnor, PA (US) (2011 - 2014)
Spring House, PA (US) (2018 - 2019)
Norristown, PA (US) (2019 - 2024)

Company Filing History:

10 out of 435

Janssen Biotech, Inc.

patents

1 out of 31

Centocor Ortho Biotech Inc.

patents

Years Active: 2011-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12202892 - Method of administration of an anti-IFN-α/-ω antibody (2025-01-21),

2. 12009079 - Type I interferon signatures and methods of use (2024-06-11),

3. 11578124 - Safe and effective method of treating lupus with anti-IL12/IL23 antibody (2023-02-14),

4. 10759854 - Interferon alpha and omega antibody antagonists (2020-09-01),

5. 10358491 - Interferon alpha and omega antibody antagonists (2019-07-23),

6. 10208113 - Interferon α and ω antibody antagonists (2019-02-19),

7. 10155809 - Interferon alpha and omega antibody antagonists (2018-12-18),

8. 9902770 - Interferon alpha and omega antibody antagonists (2018-02-27),

9. 8895700 - Monkey homolog of human interferon omega (2014-11-25),

10. 8895263 - Methods for suppressing toll-like receptor activity (2014-11-25),

11. 8084232 - [object Object] (2011-12-27),

Title: The Innovative Contributions of Jarrat Jordan

Introduction

Jarrat Jordan is a notable inventor based in Spring House, PA, with a remarkable portfolio of 11 patents. His work primarily focuses on advancements in medical treatments, particularly in the field of immunology.

Latest Patents

Among his latest patents is a method of administration of an anti-IFN-α/-ω antibody. This patent outlines methods for administering the antibody either subcutaneously or intravenously in clinically proven safe amounts. Additionally, it provides methods for the safe treatment of IFN-I mediated diseases, such as systemic lupus erythematosus (SLE). Another significant patent involves Type I interferon (IFN-I) signatures, which are instrumental in diagnosing whether a patient with an IFN-I mediated disease will respond to treatment with an IFN-I inhibitor.

Career Highlights

Jarrat Jordan has made significant contributions to the pharmaceutical industry through his work at prominent companies. He has been associated with Janssen Biotech, Inc. and Centocor Ortho Biotech Inc., where he has played a crucial role in developing innovative medical solutions.

Collaborations

Throughout his career, Jarrat has collaborated with talented individuals, including Chichi Huang and Ellen Chi. Their combined expertise has contributed to the success of various projects and advancements in their field.

Conclusion

Jarrat Jordan's innovative contributions to medical science, particularly in the treatment of IFN-I mediated diseases, highlight his importance as an inventor. His patents and collaborations reflect a commitment to improving patient care through scientific advancements.

Profile summary based on public USPTO records.